本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Disc Medicine

86.17
-1.0000-1.15%
盘后86.170.00000.00%18:51 EDT
成交量:174.33万
成交额:1.50亿
市值:29.96亿
市盈率:-19.01
高:88.10
开:85.64
低:85.02
收:87.17
52周最高:95.95
52周最低:30.82
股本:3,476.56万
流通股本:2,867.62万
量比:1.88
换手率:6.08%
股息:- -
股息率:- -
每股收益(TTM):-4.5319
每股收益(LYR):-3.9613
净资产收益率:-26.36%
总资产收益率:-17.95%
市净率:4.88
市盈率(LYR):-21.75

数据加载中...

2024/06/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/20

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/04/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

重要事件披露

Form 8-K - Current report
2024/03/21

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/21

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/21

重要事件披露

Form 8-K - Current report
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/26

重要事件披露

Form 8-K - Current report
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

重要事件披露

Form 8-K - Current report
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]